Both in Biotechnology
Eikon Therapeutics vs Surrozen
Over the past year EIKN returned −64.1% and SRZN returned +39.2%; their daily moves had a correlation of 0.20.
EIKN −64.1% SRZN +39.2%Growth of $1, one year, split-adjusted
| Metric | EIKN | SRZN |
|---|---|---|
| Price | $5.38 | $29.59 |
| Market cap | $291.4M | $347.7M |
| Today | −5.28% | +1.95% |
| 1 month | −28.6% | +1.6% |
| 6 months | −47.7% | −9.4% |
| Year to date | — | +30.9% |
| 1 year | — | +111.3% |
| Revenue growth (YoY) | — | +408.6% |
| Gross margin | — | 100.0% |
| Net margin | — | 640.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 30.2× |
| Net cash | $531.2M | $102.0M |
| Dividend yield | — | — |
| Volatility (60d) | 100.3% | 170.6% |
| Short % of float | 20.4% | 37.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).